The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Try the newly designed Company Pages!
Switch now

Allergan

  • AGN
  • NYSE
  • Consumer Products
  • Latest 184.21
  • Currency US$
  • Change 0.84
  • Percent Change 0.458 %
  • Volume 1,750,983
  • Fri Oct 24, 2014 04:00 PM EDT NYSE data delayed 15 minutes.
  • Open 183.77
  • Previous Close 183.37
  • High 186.86
  • Low 183.21
  • Bidx24 183.00
  • Askx1 192.08
  • 52-week High10/09 192.98
  • 52-week Low11/07 88.34
  • Beta 0.728
  • Market Cap 54,813.53M
  • EPS 4.75
  • P/E 38.781
  • Forward P/E 21.49
  • PEG 1.60
  • Annual Dividend 0.20
  • Yield 0.109

News

Financials & Calendars

Income Statement

  • Sales $6,753,400,000
  • Earnings $1,287,200,000
  • Return on Equity n/a

Cash Flow

  • Cash Flow --
  • Cash n/a
  • Current Ratio 4.05

12 months ended Jun 30, 2014.

Trailing 12 month results shown above.
All data is in U.S. dollars.

Balance Sheet

  • Assets $10,990,800,000
  • Liabilities $4,196,500,000
  • Liabilities-to-Equity Ratio 0.62

Price Ratios

  • Price to Sales 8.12
  • Price to Book 8.07
  • Price to Cash Flow n/a

Event Calendar

Event Last   Next  
Earnings Jul 21 $1.44 Nov 4 $1.76
Surprises Jul 21 4.86% n/a n/a
Dividends Aug 13 $0.05 n/a n/a
Splits n/a -- n/a n/a

12 months ended Oct 24, 2014.

A look at major corporate events and financial announcements that are coming up.

Company Information

About the Company

Allergan, Inc. is a provider of eye care and specialty pharmaceutical products throughout the world with products in the eye care pharmaceutical, ophthalmic surgical device, over-the-counter contact lens care, movement disorder, and dermatological markets. Its worldwide consolidated revenues are principally generated by prescription and non-prescription pharmaceutical products in the areas of ophthalmology and skin care, neurotoxins, intraocular lenses and other ophthalmic surgical products, and contact lens care products.

Related Securities
Symbol Type Latest % Chg

Officers

  • David E.I. Pyott Chairman and C.E.O.
  • Douglas S. Ingram President
  • Company Type: n/a
  • Company Status: n/a
  • Full-time Employees: n/a
  • Incorporation: United States,
    n/a
  • Top 1000 Ranking: Profit: n/a
    Revenue: n/a
    Assets: n/a

Head Office

2525 DUPONT DRIVE
IRVINE, CA
92713-9

Phone: (714)-246-4500
Fax: (714)-2466987


www.allergan.com

Ideas & Discussion

Live Discussion of AGN on StockTwits
The Globe and Mail has
updated our Company Pages
Switch to the newly designed Company Pages format today for a more in-depth look at the companies you're following and pages that are easier to navigate. If you prefer the old layout after trying the new Company Pages, you can switch back anytime.